PHARMA CONNEXIONS
DEAD

Serial Number

86030056

Owner

TELERx Marketing, Inc.

Attorney

James A. Thomas

Filing Date

Aug 6, 2013

Add to watchlist:

No watchlists yet
View on USPTO

PHARMA CONNEXIONS Trademark

Serial Number: 86030056

PHARMA CONNEXIONS is a trademark filed by TELERx Marketing, Inc. on August 6, 2013. The trademark is classified under Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

TELERx Marketing, Inc. (38 trademarks)

Springhouse, PA 19477

Entity Type: 03

Trademark Details

Filing Date

August 6, 2013

Registration Date

Not Registered

Published for Opposition

January 6, 2015

Goods & Services

Telecommunications services provided via an interactive voice response system, namely, call routing, call forwarding, call screening, call recording, telephone voice messaging, electronic messaging services to deliver information to customers of others

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, pharmaceutical benefit management services, including verification of benefit eligibility and patient enrollment

Customer service management and customer relationship management services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement programs, and healthcare and consumer packaged goods; business process outsourcing services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement (A and R) programs, and healthcare and consumer packaged goods (CPG), namely, providing consumers with information about products and services of others in response to consumer interactions such as inquiries and complaints, and using such inquiries to increase product/service sales via inbound up-selling and cross-selling of products and services, increase repeat purchases and lifetime value, and improve and increase brand loyalty; order fulfillment services; administration of patient reimbursement programs with regard to medication and treatment; marketing analysis services to provide trends and to gain insight into consumer behavior; business and marketing services for others provided via an interactive voice response system, namely, processing telephone inquiries regarding products and services of others, responding to customer inquiries regarding products and services of others, and telephone order-taking services; administration of patient support and adherence programs featuring appointment scheduling services, physician referrals, and customer follow-ups for customer service and business purposes; marketing analysis and marketing services, namely, monitoring and administration of branded social media advertising for others

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing information, advice, and consulting in the field of drug safety and pharmacovigilance as it relates to drug safety; providing drug safety services and pharmacovigilance services related to drug safety, namely, collecting, analyzing, and processing data related to adverse events and product quality complaints, aggregate reporting of adverse events and product quality complaints, and product life cycle case handling related to adverse events and product quality complaints

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing and administering disease management programs including remote assistance, advice, and support; patient support and adherence services, namely, providing doctor's appointment and prescription refill reminder services and following up with patients to determine whether they are adhering to medical advice and taking prescribed medications

Technical support services, namely, troubleshooting of computer software problems; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 5, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 5, 2015 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 2, 2014 PREV
ASSIGNED TO LIE
Nov 26, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 10, 2014 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2014 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 10, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 10, 2014 GNSL
SUSPENSION LETTER WRITTEN
Jun 10, 2014 CNSL
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2013 NWOS
NEW APPLICATION ENTERED
Aug 9, 2013 NWAP